Date | Time | Source | Headline | Symbol | Company |
09/10/2024 | 3:00PM | iHub Newswire | FeaturedElement79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates | | |
04/19/2011 | 8:30AM | Business Wire | Forest Laboratories & Blue Ash Therapeutics Enter Into Asset Purchase Agreement for Azimilide, a Novel Phase III Antiarrhythm... | NYSE:FRX | Forest Road Acquisition Corp |
04/19/2011 | 8:00AM | Business Wire | Forest Laboratories, Inc. Reports Fiscal Year Fourth Quarter 2011 Earnings Per Share of $1.12 | NYSE:FRX | Forest Road Acquisition Corp |
04/15/2011 | 8:58AM | Marketwired | Equity Research on Teva Pharmaceutical Industries Limited and Forest Laboratories Inc. -- Drug Manufacturers Taking Different Ap | NYSE:FRX | Forest Road Acquisition Corp |
04/14/2011 | 12:30PM | Zacks | Earnings Preview: Forest Labs - Analyst Blog | NYSE:FRX | Forest Road Acquisition Corp |
04/13/2011 | 5:41PM | Business Wire | Forest Laboratories Chairman & CEO to Challenge “Unwarranted & Unprecedented” Potential Action to Exclude Him from Federa... | NYSE:FRX | Forest Road Acquisition Corp |
04/13/2011 | 5:18PM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
04/13/2011 | 4:37PM | Business Wire | Forest Laboratories Completes Acquisition of Clinical Data, Inc. | NYSE:FRX | Forest Road Acquisition Corp |
04/13/2011 | 4:27PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NYSE:FRX | Forest Road Acquisition Corp |
04/12/2011 | 10:30AM | Dow Jones News | Forest Labs Succeeds In Tender Offer For Clinical Data | NYSE:FRX | Forest Road Acquisition Corp |
04/12/2011 | 9:22AM | Business Wire | Forest Laboratories Announces Successful Completion of Tender Offer for Securities of Clinical Data, Inc. | NYSE:FRX | Forest Road Acquisition Corp |
04/11/2011 | 3:38PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
04/04/2011 | 6:44PM | Dow Jones News | CORRECT:Forest Labs Extends Tender Offer For Clinical Data By A Week | NYSE:FRX | Forest Road Acquisition Corp |
04/04/2011 | 10:30AM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
04/04/2011 | 10:16AM | Business Wire | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2011 Fourth Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
04/04/2011 | 10:03AM | Dow Jones News | Forest Labs Extends Tender Offer For Clinical Data By A Week | NYSE:FRX | Forest Road Acquisition Corp |
04/04/2011 | 8:53AM | Business Wire | Forest Laboratories Announces Amendment to Merger Agreement and Extends Tender Offer to Acquire Clinical Data, Inc. | NYSE:FRX | Forest Road Acquisition Corp |
04/04/2011 | 8:00AM | Business Wire | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2011 Third Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
04/01/2011 | 1:59PM | Dow Jones News | Cocoa In Focus In ICE, Nasdaq Bid For NYSE Euronext | NYSE:FRX | Forest Road Acquisition Corp |
03/30/2011 | 5:30AM | Zacks | Theravance Remains Neutral - Analyst Blog | NYSE:FRX | Forest Road Acquisition Corp |
03/18/2011 | 2:58PM | Business Wire | Forest Laboratories Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of Clinical Data | NYSE:FRX | Forest Road Acquisition Corp |
03/10/2011 | 3:07PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
03/08/2011 | 8:30AM | Business Wire | Forest Laboratories Commences Tender Offer for All Outstanding Shares and Certain Notes and Warrants of Clinical Data, Inc. | NYSE:FRX | Forest Road Acquisition Corp |
03/02/2011 | 4:58PM | Dow Jones News | Forest Labs Ordered To Pay $150 Million Fine For Criminal Violations | NYSE:FRX | Forest Road Acquisition Corp |
03/01/2011 | 1:33PM | Dow Jones News | FDA Approves Forest Laboratories Drug To Treat Lung Disease | NYSE:FRX | Forest Road Acquisition Corp |
03/01/2011 | 4:00AM | Business Wire | Forest Announces FDA Approval of DalirespTM (Roflumilast) as a Treatment to Reduce the Risk of COPD Exacerbations in Patients... | NYSE:FRX | Forest Road Acquisition Corp |
02/28/2011 | 12:12PM | Business Wire | Kendall Law Group Investigates Forest Laboratories, Inc. for Shareholders | NYSE:FRX | Forest Road Acquisition Corp |
02/28/2011 | 2:00AM | Business Wire | Forest Laboratories, Inc. & Gedeon Richter Plc Announce Results from a Phase II Study of Cariprazine as Adjunctive Therapy in... | NYSE:FRX | Forest Road Acquisition Corp |
02/25/2011 | 4:48PM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
02/24/2011 | 2:56PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |